TA
Tectonic Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $660K | Buy |
1,257
+358
| +40% | +$188K | 0.04% | 209 |
|
|
2025
Q1 | $570K | Buy |
899
+69
| +8% | +$43.8K | 0.04% | 223 |
|
|
2024
Q4 | $591K | Buy |
830
+118
| +17% | +$84.1K | 0.04% | 213 |
|
|
2024
Q3 | $748K | Sell |
712
-72
| -9% | -$75.7K | 0.05% | 191 |
|
|
2024
Q2 | $824K | Buy |
784
+33
| +4% | +$34.7K | 0.06% | 180 |
|
|
2024
Q1 | $723K | Sell |
751
-32
| -4% | -$30.8K | 0.06% | 187 |
|
|
2023
Q4 | $688K | Buy |
783
+14
| +2% | +$12.3K | 0.06% | 177 |
|
|
2023
Q3 | $633K | Buy |
769
+35
| +5% | +$28.8K | 0.06% | 169 |
|
|
2023
Q2 | $527K | Buy |
734
+46
| +7% | +$33.1K | 0.06% | 188 |
|
|
2023
Q1 | $565K | Buy |
688
+158
| +30% | +$130K | 0.08% | 170 |
|
|
2022
Q4 | $382K | Sell |
530
-9
| -2% | -$6.49K | 0.06% | 193 |
|
|
2022
Q3 | $371K | Buy |
539
+41
| +8% | +$28.2K | 0.07% | 149 |
|
|
2022
Q2 | $294K | Buy |
498
+41
| +9% | +$24.2K | 0.05% | 159 |
|
|
2022
Q1 | $319K | Buy |
457
+69
| +18% | +$48.2K | 0.05% | 156 |
|
|
2021
Q4 | $245K | Buy |
+388
| New | +$245K | 0.04% | 172 |
|
|
2021
Q1 | – | Sell |
-1,133
| Closed | -$547K | – | 204 |
|
|
2020
Q4 | $547K | Buy |
+1,133
| New | +$547K | 0.15% | 93 |
|